TD Asset Management’s Ginkgo Bioworks DNA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $147K | Hold |
13,046
| – | – | ﹤0.01% | 1182 |
|
|
2025
Q1 | $74.4K | Hold |
13,046
| – | – | ﹤0.01% | 1212 |
|
|
2024
Q4 | $128K | Hold |
13,046
| – | – | ﹤0.01% | 1237 |
|
|
2024
Q3 | $106K | Sell |
13,046
-508,808
| -98% | -$4.12M | ﹤0.01% | 1376 |
|
|
2024
Q2 | $174K | Hold |
521,854
| – | – | ﹤0.01% | 1345 |
|
|
2024
Q1 | $605K | Hold |
521,854
| – | – | ﹤0.01% | 1265 |
|
|
2023
Q4 | $882K | Hold |
521,854
| – | – | ﹤0.01% | 1198 |
|
|
2023
Q3 | $945K | Buy |
521,854
+260,927
| +100% | +$472K | ﹤0.01% | 1156 |
|
|
2023
Q2 | $485K | Hold |
260,927
| – | – | ﹤0.01% | 1271 |
|
|
2023
Q1 | $347K | Hold |
260,927
| – | – | ﹤0.01% | 1319 |
|
|
2022
Q4 | $441K | Hold |
260,927
| – | – | ﹤0.01% | 1305 |
|
|
2022
Q3 | $817K | Hold |
260,927
| – | – | ﹤0.01% | 1217 |
|
|
2022
Q2 | $621K | Sell |
260,927
-292,580
| -53% | -$696K | ﹤0.01% | 1256 |
|
|
2022
Q1 | $2.23M | Buy |
553,507
+259,904
| +89% | +$1.05M | ﹤0.01% | 1057 |
|
|
2021
Q4 | $2.44M | Buy |
293,603
+203,903
| +227% | +$1.69M | ﹤0.01% | 1085 |
|
|
2021
Q3 | $1.04M | Buy |
+89,700
| New | +$1.04M | ﹤0.01% | 1243 |
|